首页 › 基金 › NAN FUNG TRINITY (HK) Ltd › CLYM

NAN FUNG TRINITY (HK) Ltd 对 CLYM 的持仓历史

CLIMB BIO INC · 医疗保健

NAN FUNG TRINITY (HK) Ltd 在 Q3 2026 的 13F 申报中披露持有 CLYM(CLIMB BIO INC)360,654 股,市值约 US$4.1M,约占其申报组合的 0.40%,在其申报持仓中市值排名第 49 位。 NAN FUNG TRINITY (HK) Ltd 最近 6 个申报季度中有 6 个季度披露了 CLYM 持仓,最早可追溯至 Q2 2025。

最新持仓 (Q3 2026)360.65K 股
申报持仓市值$4.14M
组合权重0.40%
首次申报Q2 2025
最近变动持有
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

NAN FUNG TRINITY (HK) Ltd 对 CLYM 的持仓演变

NAN FUNG TRINITY (HK) Ltd 于 Q2 2025 首次披露 CLYM 持仓:463,654 股(约 US$575K)。 该持仓在 Q2 2026 达到峰值 360,654 股,市值约 US$4.7M。 在 6 次申报中,NAN FUNG TRINITY (HK) Ltd 0 次增持、2 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 360,654 股、市值约 US$4.1M。

逐季持仓明细

季度股数金额变化
Q2 2025 463.65K $574.93K 新进
Q3 2025 463.65K $931.95K 持有
Q4 2025 463.65K $1.85M 持有
Q1 2026 420.52K $2.88M 减持
Q2 2026 360.65K $4.70M 减持
Q3 2026 360.65K $4.14M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CLYM 与 13F 数据

CLYM(CLIMB BIO INC)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 CLYM,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CLYM 的基金

查看 CLYM 的全部基金持有人 →

常见问题

How long has NAN FUNG TRINITY (HK) Ltd held CLYM?

NAN FUNG TRINITY (HK) Ltd has disclosed CLYM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is NAN FUNG TRINITY (HK) Ltd's current position in CLYM?

As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 360.65K shares of CLYM (CLIMB BIO INC), valued at $4.14M, representing 0.40% of its reported portfolio and ranking #49.

Has NAN FUNG TRINITY (HK) Ltd been buying or selling CLYM?

In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd held unchanged its position in CLYM. The position peaked in Q2 2026 at 360.65K shares.

Which other funds hold CLYM?

Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.